Concepedia

The continuing evolution of the drug discovery process in the pharmaceutical industry

Emiliangelo Ratti, David G. Trist

Il Farmaco · 2001 · 36 citations · 4 references

DOI

Concepts

References

4

Definition and Antagonism of Histamine H2-receptors

J. W. Black, W. A. M. Duncan, C. J. DURANT et al. · Nature · 1972 · 2.3K citations

, , +12

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists

B. Evans, Kenneth E. Rittle, Mark G. Bock et al. · Journal of Medicinal Chemistry · 1988 · 1.4K citations · Full text

, , +13

Pharmaceutical innovation by the seven UK‐owned pharmaceutical companies (1964‐1985).

RA Prentis, Y. Lis, SR Walker · British Journal of Clinical Pharmacology · 1988 · 473 citations · Full text

, , +6

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.

B. Evans, Mark G. Bock, Kenneth E. Rittle et al. · Proceedings of the National Academy of Sciences · 1986 · 328 citations · Full text

, , +16